Sort
21,453 grants matching “tuberculosis”
ROLE OF IL-17 IN PROTECTIVE VACCINE-INDUCED IMMUNE RESPONSES AGAINST TUBERCULOSIS
$426,417Shabaana A. Khader · Washington University · R01 · FY2017 · HL
The ecology of environmentally maintained episodic anthrax in Esotha, Namibia
$426,303Wayne M Getz · University Of California Berkeley · R01 · FY2009 · GM
The Role of the Granuloma in M. Tuberculosis Infections
$426,261David G Russell · Cornell University · R01 · FY2015 · HL
TB VACCINE TESTING
$426,223Karen Dobos · Colorado State University · N01 · FY2011 · AI
ROLE OF ESXG-ESXH IN MYCOBACTERIUM TUBERCULOSIS PATHOGENESIS
$426,149Jennifer A Philips · Washington University · R01 · FY2021 · AI
RCT of Russian IDU Peer Network HIV Prevent Intervention
$426,106Carl A Latkin · Johns Hopkins University · R01 · FY2007 · DA
Gene regulation and virulence in TB
$425,724William Ramses Bishai · Johns Hopkins University · R01 · FY2013 · AI
Direct quantitation of the circulating Mtb-peptidome for pediatric TB management
$425,660Christopher J Lyon · Tulane University Of Louisiana · R01 · FY2019 · HD
The Missing Millions: Identification and infectiousness of undiagnosed tuberculosis cases in the community (the MI-TB study)
$425,645Keertan Unkha Dheda · University Of Cape Town Lung Institute · R01 · FY2019 · AI
"Determinants of T Cell Immunity to Tuberculosis Vaccines"
$425,529Steven A Porcelli · Albert Einstein College Of Medicine · P01 · FY2012 · AI
IL-26 in host defense against infection by intracellular bacteria in skin
$425,528Robert L Modlin · University Of California Los Angeles · R01 · FY2019 · AR
Biochemical And Biophysical Parasitology
$425,427Fuyuki Tokumasu · Niaid Extramural Activities · Z01 · FY2007 · AI
Host- and pathogen-specific risk factors for post-tuberculosis lung disease among people successfully treated for TB in Lima, Peru: Beat-PTLD
$425,383Carole D Mitnick · Harvard Medical School · R01 · FY2025 · HL
Antifolates Against Mycobacterial Infections in AIDS
$425,369Oklahoma State University Stillwater · R01 · FY2002 · AI
Antifolates Against Mycobacterial Infections in AIDS
$425,369Oklahoma State University Stillwater · R01 · FY2003 · AI
T cell Responses to CD1-restricted Lipids in Tuberculosis
$425,337David Branch Moody · Brigham And Women'S Hospital · R01 · FY2017 · AI
Core A Mouse Genetics and Genomics Core
$425,317Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · AI
Framework to Address Drug Resistant Infections and Global Health
$425,303Lee W Riley · University Of California Berkeley · R24 · FY2010 · TW
Overcoming Genetic Variation in Vaccination
$425,214Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · P01 · FY2021 · AI
CENTERS FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES
$425,194Bart Staker · Seattle Children'S Hospital · N01 · FY2025 · AI
A Novel Gyrase Inhibitor for the Treatment of Drug-susceptible and Multidrug-resistant Mycobacterium tuberculosis Infections
$425,178Michael J Pucci · Spero Therapeutics, Inc. · R44 · FY2018 · AI
Genetic Analysis of Histoplasma-Macrophage Interactions
$425,169University Of California Berkeley · P01 · FY2005 · AI
Sensitive and quantitative point-of-care viral load testing on paper
$425,150Hadi Shafiee · Brigham And Women'S Hospital · R01 · FY2017 · AI
Sensitive and quantitative point-of-care viral load testing on paper
$425,150Hadi Shafiee · Brigham And Women'S Hospital · R01 · FY2016 · AI
A Cambodian Clinical Research Network for HIV & TB
$425,149Sok Thim · Cambodian Health Committee · U01 · FY2011 · AI